DR. REDDY LABS $37.52

up +0.20


24/5/2013 04:24 PM  |  NYSE : RDY  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 26% - RDY has outperformed the S&P 500 by 0%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing RDY also viewed: , , , ,

Competitors

Ticker Name Volume % Change
NPCUF ALLON THERAPEUTICS INC 10.0K +1.78%
CNSO CNS RESPONSE 34.1K +1.26%
ISLT ISLET SCIENCES 78.6K +0.75%
ADLS ADVANCED LIFE SCIENCES 35.1K +0.67%
SCLR SCOLR PHARMA 427.3K +0.67%

RDY Stock Analysis

  1. Beam's North American Business Beams Brightly

    Beam (NYSE:BEAM) announced solid first quarter earnings May 2. The highlight of Q1 was the performance of its North American business, which generated huge sales and profit growth over last year. While its home market is humming, business overseas is less than stellar.
Free Reports
  1. 7 Proven Strategies for Market-Stomping Stocks

    Discover Investing Strategies that will Benefit Every Investor Today!
  2. Free Corn and Ethanol Report!

    Learn how you can take advantage of an ethanol-driven bull market in corn.
  3. 4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
Marketplace
Trading Center